Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE): Doubly-modified water-soluble derivatives of chloroorienticin B

Bioorganic and Medicinal Chemistry Letters

Volumn 12, Issue 21, 2002, Pages 3027-3031

  Yoshida, Osamu ^a   Yasukata, Tatsuro ^a   Sumino, Yukihito ^a   Munekage, Tadashi ^a   Narukawa, Yukitoshi ^a   Nishitani, Yasuhiro ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROORIENTICIN B; GLYCOPEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; VANCOMYCIN DERIVATIVE; WATER;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG SOLUBILITY; DRUG SYNTHESIS; ENTEROCOCCUS; NONHUMAN; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ENTEROCOCCUS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; SOLUBILITY; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0037020718     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00664-9     Document Type: Article

References (21)

1. Uttley A.H.C., Collins C.H., Naidoo J., George R.C. Lancet. 1:1988;57.
2. Leclercq R., Derlot E., Duval J., Couvalin P. New England J. Med. 319:1988;157.
3. Malabarba A., Nicas T.I., Thompson R.C. Med. Res. Rev. 17:1997;69.
4. Cooper M.A., Williams D.H. Chemistry & Biology. 6:1999;891.
5. Williams D.H., Bardsley B. Angew. Chem., Int. Ed. Engl. 38:1999;1172.
6. Nicolaou K.C., Boddy C.N.C., Bräse S., Winssinger N. Angew. Chem., Int. Ed. Engl. 38:1999;2096.
7. Cooper R.D., Snyder N.J., Zweifel M.J., Staszak M.A., Wilkie S.C., Nicas T.I., Mullen D.L., Butler T.F., Rodriguez M.J., Huff B.E., Thompson R.C. J. Antibiot. 49:1996;575.
8. Allen N.E., LeTourneau D.L., Hobbs J.N. Jr. J. Antibiot. 50:1997;677.
9. Rodriguez M.J., Snyder N.J., Zweifel M.J., Wilkie S.C., Stack D.R., Cooper R.D.G., Nicas T.I., Mullen D.L., Butler T.F., Thompson R.C. J. Antibiot. 51:1998;560.
10. Miroshnikova O.V., Printsevskaya S.S., Olsufyeva E.N., Pavlov A.Y., Nilius A., Hensey-Rudloff D., Preobrazhenskaya M.N. J. Antibiot. 53:2000;286.
11. Pavlov A.Y., Miroshnikova O.V., Printsevskaya S.S., Olsufyeva E.N., Preobrazhenskaya M.N., Goldman R.C., Bransrom A.A., Braizman E.R., Longley C.B. J. Antibiot. 54:2001;455.
12. Ge M., Chen Z., Onishi H.R., Kohler J., Silver L.L., Kerns R., Fukuzawa S., Thompson C., Kahne D. Science. 284:1999;507.
13. Kerns R., Dong S.D., Fukuzawa S., Carbeck J., Kohler J., Silver L., Kahne D. J. Am. Chem. Soc. 122:2000;12608.
14. Zeckel M.L., Preston D.A., Allen B.S. Antimicrob. Agents Chemother. 44:2000;1370
15. Malabarba A., Ciabatti R. Curr. Med. Chem. 8:2001;1759, and references cited therein.
16. Pavlov A.Y., Preobrazhenskaya M.N., Malabarba A., Ciabatti R., Colombo L. J. Antibiot. 51:1998;73.
17. Tsuji N., Kamigauchi T., Kobayashi M., Terui Y. J. Antibiot. 41:1988;1506.
18. Preliminary experiments revealed that the N-terminus secondary amino group of the peptide backbone was more reactive than the amino sugar nitrogen, therefore protection of N-terminus amino group was found to be necessary prior to reductive N-alkylation.
19. Minimum Inhibitory Concentrations (MICs) were determined by National Committee for Clinical Laboratory Standards (NCCLS)-recommended microbroth dilution methods using cation-adjusted Mueller Hinton broth (Difco Laboratories, Detroit, MI, USA).
20. Pavlov A.Y., Lazhko E.I., Preobrazhenskaya M.N. J. Antibiot. 50:1997;509.
21. Histamine dihydrochloride was used for aminomethylation of 2d.